Derma Sciences, Inc. announced the U.S. launch and first commercial sales of Medihoney HCS (hydrogel colloidal sheet) for the treatment of first- and second-degree burns, in addition to various chronic and acute wounds.

The product contains Super Absorbent Polymer technology to help modulate MMPs (protease enzymes that cause delayed healing) from the wound environment. Medihoney HCS will be able to handle up to 2.5 times the amount of fluid of market-leading hydrocolloids, while also providing a moist environment for dry wounds.

Medihoney HCS is a dressing comprising a combination of the Company’s Medihoney and Xtrasorb HCS dressings.

For more information call (609) 514-4744 or visit